PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California, USA.\', \'Department of Infectious Diseases, Kaiser Permanente Northern California, Oakland, California, USA.\', \'COVID-19 Response Team, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/irv.12901
?:doi
?:hasPublicationType
?:journal
  • Influenza and other respiratory viruses
is ?:pmid of
?:pmid
?:pmid
  • 34432371
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.966
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • Population-based assessment of risks for severe COVID-19 disease outcomes.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all